샘플 요청 목록

 카트 문의
시장보고서
상품코드
1625480

귀두염 치료 시장 규모, 점유율, 동향, 산업 분석 보고서 : 치료 유형별, 유통 채널별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)

Balanoposthitis Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment Type, Distribution Channel, End Use, and Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 120 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 귀두염 치료 시장 규모는 2034년까지 1억 9,935만 달러에 달할 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

귀두염 치료 시장은 음경의 귀두(두부)와 포피의 염증을 특징으로 하는 상태인 귀두염을 관리하는데 사용되는 의료 치료 및 개입 시장을 말합니다. 이 염증은 부위생, 감염(세균성, 바이러스성, 진균성), 성감염증(STI), 당뇨병, 알레르기 반응 등 다양한 요인으로 인해 발생합니다. 귀두염의 치료에는 근본 원인에 따라 국소 항진균제, 항생제, 항염증제의 병용이 일반적입니다.

세계 당뇨병 이환율 증가가 고환 늑막염 치료 시장 수요를 견인하고 있습니다. 당뇨병 환자는 소변 중의 포도당 농도가 높기 때문에 감염증에 걸리기 쉽고, 이것이 이스트균 감염이나 포피·귀두의 염증으로 이어집니다. 게다가, STI의 이환율이 증가하고 있는 것도 귀두염 환자 증가에 기여하고 있습니다. 헤르페스와 클라미디아와 같은 특정 성 감염은 귀두와 포피의 염증과 감염을 유발하며 치료가 필요합니다. 국소 치료의 진보와 온라인 약국의 확대가 시장 기회를 촉진하고 있습니다. 보다 효과적이고 환자 친화적인 외용 요법의 개발은 치료의 충격과 치료 성적을 향상시킬 것입니다. 게다가, 섬세한 치료를 눈에 띄지 않게 이용할 수 있는 온라인 약국의 편의성은 특히 건강 관리 시설에 대한 접근이 제한된 지역에서의 성장을 가속할 것으로 예상됩니다.

귀두염 치료 시장은 특히 개인의 위생과 성감염증(STI)과 관련된 질병에 대한 의식이 높아지는 것이 큰 원동력이 되어 큰 성장이 예상되고 있습니다. 또한 STI의 예방과 관리에 중점을 둔 공중 보건 활동과 교육 캠페인의 강화가 인지도 향상에 기여하고 있습니다. 이러한 이해의 고조가 조기 진단·조기 치료로 연결되어 귀두염 치료제 수요를 더욱 밀어 올리고 있습니다.

귀두염 치료 시장 보고서 하이라이트

2024년 외용 치료제 부문은 전신적 부작용을 최소화하고 환자에게 적용하기 쉽고 완만한 완화를 제공하는 효과로 귀두염 치료 시장에서 큰 수익 점유율을 차지했습니다.

온라인 약국 부문은 편리하고 눈에 띄지 않는 치료에 대한 액세스에 대한 소비자의 선호도 증가와 디지털 플랫폼을 통해 광범위한 제품을 이용할 수 있게 되었으며, 상당한 CAGR로 성장하고 있습니다.

2024년 북미는 첨단 의료 인프라, 높은 의료비, 감염 대책 및 환자 안전을 위한 일회용 의료 제품의 채용 증가로 귀두염 치료 시장에서 큰 시장 점유율을 차지하고 있습니다.

아시아태평양은 건강 관리 의식이 증가하고 당뇨병과 성 감염의 유병률이 증가함에 따라 예측 기간 동안 크게 성장할 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 귀두염 치료 시장 인사이트

  • 시장 현황
  • 귀두염 치료 시장 역학
    • 성장 촉진요인과 기회
      • 성감염증의 발생률 상승
      • 당뇨병 이환율 상승
    • 성장 억제요인과 과제
      • 특정 지역에서 한정되어 있는 고도의 치료 옵션
  • PESTEL 분석
  • 귀두염 치료 시장의 응용 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 귀두염 치료 시장 : 치료 유형별

  • 주요 조사 결과
  • 소개
  • 국소 치료
  • 경구약
  • 외과적 치료

제6장 세계의 귀두염 치료 시장 : 유통 채널별

  • 주요 조사 결과
  • 소개
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제7장 세계의 귀두염 치료 시장 : 최종 용도별

  • 주요 조사 결과
  • 소개
  • 병원 및 진료소
  • 외래수술센터(ASC)
  • 가정치료 환경

제8장 세계의 귀두염 치료 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 귀두염 치료 시장 평가 : 지역별(2020-2034년)
  • 북미
    • 북미 : 치료 유형별(2020-2034년)
    • 북미 : 유통 채널별(2020-2034년)
    • 북미 : 최종 용도별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 치료 유형별(2020-2034년)
    • 유럽 : 유통 채널별(2020-2034년)
    • 유럽 : 최종 용도별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 치료 유형별(2020-2034년)
    • 아시아태평양 : 유통 채널별(2020-2034년)
    • 아시아태평양 : 최종 용도별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 치료 유형별(2020-2034년)
    • 중동 및 아프리카 : 유통 채널별(2020-2034년)
    • 중동 및 아프리카 : 최종 용도별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 치료 유형별(2020-2034년)
    • 라틴아메리카 : 유통 채널별(2020-2034년)
    • 라틴아메리카 : 최종 용도별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 확장 및 인수 분석
    • 확장
    • 인수
  • 파트너십/협업/계약/공개

제10장 기업 프로파일

  • AbbVie Inc.
  • Bayer AG
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline plc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals
KTH 25.02.03

The global balanoposthitis treatment market size is expected to reach USD 199.35 million by 2034, according to a new study by Polaris Market Research. The report "Global Balanoposthitis Treatment Market Size, Share, Trends, Industry Analysis Report, By Treatment Type (Topical Treatments, Oral Medications, and Surgical Treatments), Distribution Channel, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Segment Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The balanoposthitis treatment market refers to the market for medical therapies and interventions used to manage balanoposthitis, a condition characterized by inflammation of the glans (head) and foreskin of the penis. This inflammation is caused by various factors, including poor hygiene, infections (bacterial, viral, or fungal), sexually transmitted infections (STIs), diabetes, and allergic reactions. The treatment of balanoposthitis typically involves a combination of topical antifungals, antibiotics, and anti-inflammatory agents, depending on the underlying cause.

The increasing prevalence of diabetes worldwide is driving demand for balanoposthitis treatment market. Diabetic individuals are more susceptible to infections due to higher glucose levels in the urine, which leads to yeast infections and irritations of the foreskin and glans. Furthermore, the rising incidence of STIs, which are contributing to an increase in balanoposthitis cases. Certain STIs, such as herpes and chlamydia, lead to inflammation and infection of the glans and foreskin, necessitating medical treatment. Advancements in topical treatments and the expansion of online pharmacies are fueling market opportunities. The development of more effective and patient-friendly topical therapies is likely to improve treatment adherence and outcomes. Additionally, the convenience of online pharmacies, which offer discreet access to sensitive treatments, is expected to drive growth, particularly in regions where access to healthcare facilities is limited.

The balanoposthitis treatment market is poised for significant growth, largely driven by increasing awareness of the condition, particularly in relation to personal hygiene and sexually transmitted infections (STIs). Additionally, enhanced public health initiatives and educational campaigns focusing on STI prevention and management are contributing to greater awareness. This heightened understanding is leading to earlier diagnosis and treatment, further driving the demand for balanoposthitis therapies.

Balanoposthitis Treatment Market Report Highlights

In 2024, the topical treatments segment accounted for a significant revenue share in the balanoposthitis treatment market due to their effectiveness in providing targeted relief with minimal systemic side effects and ease of application for patients.

The online pharmacies segment is growing at a substantial CAGR due to the increasing consumer preference for convenient, discreet access to treatments, coupled with the expanding availability of a wide range of products through digital platforms.

In 2024, North America accounted for a substantial market share in the balanoposthitis treatment market due to its advanced healthcare infrastructure, high healthcare expenditure, and increased adoption of disposable medical products for infection control and patient safety.

The Asia Pacific region is expected to grow significantly in the forecast period due to rising healthcare awareness and increasing prevalence of diabetes and sexually transmitted infections.

The global key market players include AbbVie Inc.; Bayer AG; Cipla Limited; Dr. Reddy's Laboratories; GlaxoSmithKline plc.; Johnson & Johnson; Novartis AG; Pfizer Inc.; Sanofi S.A; Sun Pharmaceutical Industries Ltd.; and Teva Pharmaceuticals.

Polaris Market Research has segmented the balanoposthitis treatment market report based on treatment type, distribution channel, end use, and region:

By Treatment Type Outlook (Revenue - USD Million, 2020-2034)

  • Topical Treatments
  • Antifungal Creams
  • Antibiotic Ointments
  • Corticosteroid Creams
  • Antiseptic Solutions
  • Oral Medications
  • Antibiotics
  • Antifungals
  • Surgical Treatments
  • Circumcision
  • Preputioplasty

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End Use Outlook (Revenue - USD Million, 2020-2034)

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Balanoposthitis Treatment Market Insights

  • 4.1. Balanoposthitis Treatment Market - Market Snapshot
  • 4.2. Balanoposthitis Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidence of Sexually Transmitted Infections Are Driving Market Growth
      • 4.2.1.2. Rising Prevalence of Diabetes Are Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Availability of Advanced Treatment Options in Certain Regions
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Balanoposthitis Treatment Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Balanoposthitis Treatment Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • 5.3. Topical Treatments
    • 5.3.1. Global Balanoposthitis Treatment Market, by Topical Treatments, by Region, 2020-2034 (USD Million)
    • 5.3.2. Antifungal Creams
      • 5.3.2.1. Global Balanoposthitis Treatment Market, by Antifungal Creams, by Region, 2020-2034 (USD Million)
    • 5.3.3. Antibiotic Ointments
      • 5.3.3.1. Global Balanoposthitis Treatment Market, by Antibiotic Ointments, by Region, 2020-2034 (USD Million)
    • 5.3.4. Corticosteroid Creams
      • 5.3.4.1. Global Balanoposthitis Treatment Market, by Corticosteroid Creams, by Region, 2020-2034 (USD Million)
    • 5.3.5. Antiseptic Solutions
      • 5.3.5.1. Global Balanoposthitis Treatment Market, by Antiseptic Solutions, by Region, 2020-2034 (USD Million)
  • 5.4. Oral Medications
    • 5.4.1. Global Balanoposthitis Treatment Market, by Oral Medications, by Region, 2020-2034 (USD Million)
    • 5.4.2. Antibiotics
      • 5.4.2.1. Global Balanoposthitis Treatment Market, by Antibiotics, by Region, 2020-2034 (USD Million)
    • 5.4.3. Antifungals
      • 5.4.3.1. Global Balanoposthitis Treatment Market, by Antiseptic Solutions, by Region, 2020-2034 (USD Million)
  • 5.5. Surgical Treatments
    • 5.5.1. Global Balanoposthitis Treatment Market, by Surgical Treatments, by Region, 2020-2034 (USD Million)
    • 5.5.2. Circumcision
      • 5.5.2.1. Global Balanoposthitis Treatment Market, by Circumcision, by Region, 2020-2034 (USD Million)
    • 5.5.3. Preputioplasty
      • 5.5.3.1. Global Balanoposthitis Treatment Market, by Preputioplasty, by Region, 2020-2034 (USD Million)

6. Global Balanoposthitis Treatment Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Balanoposthitis Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Global Balanoposthitis Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
  • 6.5. Online Pharmacies
    • 6.5.1. Global Balanoposthitis Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

7. Global Balanoposthitis Treatment Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Hospitals and Clinics
    • 7.3.1. Global Balanoposthitis Treatment Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Balanoposthitis Treatment Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Million)
  • 7.5. Homecare Settings
    • 7.5.1. Global Balanoposthitis Treatment Market, by Homecare Settings, by Region, 2020-2034 (USD Million)

8. Global Balanoposthitis Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Balanoposthitis Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Balanoposthitis Treatment Market - North America
    • 8.3.1. North America: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.3. North America: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. Balanoposthitis Treatment Market - U.S.
      • 8.3.4.1. U.S.: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. Balanoposthitis Treatment Market - Canada
      • 8.3.5.1. Canada: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
  • 8.4. Balanoposthitis Treatment Market - Europe
    • 8.4.1. Europe: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.3. Europe: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. Balanoposthitis Treatment Market - UK
      • 8.4.4.1. UK: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. Balanoposthitis Treatment Market - France
      • 8.4.5.1. France: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.5.3. France: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. Balanoposthitis Treatment Market - Germany
      • 8.4.6.1. Germany: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. Balanoposthitis Treatment Market - Italy
      • 8.4.7.1. Italy: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. Balanoposthitis Treatment Market - Spain
      • 8.4.8.1. Spain: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. Balanoposthitis Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. Balanoposthitis Treatment Market - Russia
      • 8.4.10.1. Russia: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. Balanoposthitis Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
  • 8.5. Balanoposthitis Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. Balanoposthitis Treatment Market - China
      • 8.5.4.1. China: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.4.3. China: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. Balanoposthitis Treatment Market - India
      • 8.5.5.1. India: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.5.3. India: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. Balanoposthitis Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. Balanoposthitis Treatment Market - Japan
      • 8.5.7.1. Japan: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. Balanoposthitis Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. Balanoposthitis Treatment Market - South Korea
      • 8.5.9.1. South Korea: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. Balanoposthitis Treatment Market - Australia
      • 8.5.10.1. Australia: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. Balanoposthitis Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
  • 8.6. Balanoposthitis Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. Balanoposthitis Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. Balanoposthitis Treatment Market - UAE
      • 8.6.5.1. UAE: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. Balanoposthitis Treatment Market - Israel
      • 8.6.6.1. Israel: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. Balanoposthitis Treatment Market - South Africa
      • 8.6.7.1. South Africa: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. Balanoposthitis Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
  • 8.7. Balanoposthitis Treatment Market - Latin America
    • 8.7.1. Latin America: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. Balanoposthitis Treatment Market - Mexico
      • 8.7.4.1. Mexico: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. Balanoposthitis Treatment Market - Brazil
      • 8.7.5.1. Brazil: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. Balanoposthitis Treatment Market - Argentina
      • 8.7.6.1. Argentina: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. Balanoposthitis Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Balanoposthitis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Balanoposthitis Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Balanoposthitis Treatment Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr. Reddy's Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. GlaxoSmithKline plc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi S.A
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sun Pharmaceutical Industries Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Teva Pharmaceuticals
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제